Kentucky pediatric trial will study COVID-19 Pfizer vaccine in children ages 5-11
The trial will look at, in part, what dosage is right for young children and if they should be given the same as adults. |!| Louisville
The trial will look at, in part, what dosage is right for young children and if they should be given the same as adults. |!| Louisville